# Octapharma Plasma, Inc. - Norfolk – FDA Inspection, Dec 5, 2019

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc-norfolk/9635dc2b-9194-490b-a9b2-6e1da4be41d7
Source feed: FDA_Inspections

> FDA inspection 1116508 of Octapharma Plasma, Inc. - Norfolk, December 05, 2019. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1116508
- Company Name: Octapharma Plasma, Inc. - Norfolk
- Inspection Date: 2019-12-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1297062 - 2025-12-10
- FDA Inspection 1008325 - 2017-03-14
- FDA Inspection 903101 - 2014-11-05
- FDA Inspection 798467 - 2012-09-11
- [FDA Inspection 741058 - 2011-08-15](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc-norfolk/15398483-a1c3-4c4d-a9dd-f89bbf41df08)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc-norfolk/4eabc995-0fa8-48ba-bdc9-3d67289f1931

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d